Ajay Kumar: Creating a new article

2023-09-28T16:56:31Z

Creating a new article

New page

{{Short description|Indian company}}
{{Infobox company
| name = Meril Life Sciences
| logo = Meril Life Science.gif
| logo_size =
| logo_upright = 
| logo_alt =
| logo_caption =
| image =Meril Life Sciences, Vapi.jpg
| image_size =
| image_upright = 
| image_alt =
| image_caption =Headquarters at [[Vapi]], Gujarat
| type = Private
| industry = [[Medical device]]<br>Health care
| founded = {{Start date and age|2006}}
| founder =
| hq_location =
| hq_location_city = [[Vapi]], Gujarat
| hq_location_country = India
| num_locations =
| num_locations_year = 
| area_served = Worldwide
| key_people =
| products =
| production =
| production_year = 
| brands =
| services =
| owner = Bilakhia Group
| num_employees = 4000+
| num_employees_year = 2022
| parent = Bilakhia Holdings
| divisions =
| subsid =
| website = {{URL|https://www.merillife.com/}}
| footnotes =
}}
'''Meril Life Sciences''' is an Indian multinational [[medical device]] company, with headquarters in [[Vapi]], Gujarat, India. It was founded in 2006 and is a part of the Bilakhia Group.<ref name="business-standard">{{cite news |last1=Das |first1=Sohini |title=Vapi firm becomes India's first to take on Abbott in biodegradable stents |url=http://www.business-standard.com/article/companies/vapi-based-meril-emerges-challenger-to-mnc-giant-abbott-in-bvs-category-117022400368_1.html |publisher=[[Business Standard]] |archive-url=http://web.archive.org/web/20170224211913/http://www.business-standard.com/article/companies/vapi-based-meril-emerges-challenger-to-mnc-giant-abbott-in-bvs-category-117022400368_1.html |archive-date=February 24, 2017}}</ref> The company is engaged in the manufacturing of [[vascular]] intervention devices, orthopedic implants, endosurgery, [[Ear, Nose and Throat|ENT]] products and [[In vitro diagnostics|in-vitro diagnostics]]. Meril Life Sciences operates in over 100 countries and has employed 4000 people, as of 2022.<ref name="indiatimes"/>

It develops and manufactures healthcare technologies and therapies.<ref>{{cite web |last1=Kent |first1=Chloe |title=Meril Life Sciences: leading a growing Indian medtech sector |url=https://www.medicaldevice-network.com/features/indian-medical-device-industry/ |publisher=MedicalDevice-Network |date=August 20, 2019}}</ref>
The company has also developed the MeRes100 bioresorbable scaffold (BRS), which is India's first domestically produced bio-resorbable scaffold for the treatment of [[coronary artery disease]].<ref name="business-standard"/><ref>{{cite news |last1=Anand |first1=Aditya |title=Meril Life Sciences receives European certification for stents |url=https://www.thehindu.com/news/cities/mumbai/meril-life-sciences-receives-european-certification-for-stents/article29103944.ece |publisher=[[The Hindu]] |date=August 16, 2019}}</ref>

== History ==
Meril Life Sciences was established in 2006 as a part of the Bilakhia Group's healthcare diversification plan.

In February 2022, the company raised funding of US$210 million (₹15.75 billion crores)<ref name="vccircle">{{cite news |last1=Parmar |first1=Beena |title=Warburg Pincus To Invest $210 Mn In Medical Devices Firm Micro Life Sciences |url=https://www.vccircle.com/warburg-pincus-to-invest-210-mn-in-medical-devices-firm-micro-life-sciences |publisher=[[VCCircle]] |date=February 21, 2022}}</ref> from the private equity firm [[Warburg Pincus]], facilitated through its Dutch affiliate, South Elm Investments BV.<ref name="indiatimes">{{cite news |title=Warburg Pincus to invest $ 210 million in medical devices firm Meril |url=http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/warburg-pincus-to-invest-210-million-in-medical-devices-firm-meril/articleshow/89731986.cms?from=mdr |publisher=[[The Economic Times]] |date=February 22, 2022}}</ref>

== Operations ==
It operates in more than 100 countries. It has established subsidiaries in countries such as the United States, Germany, Turkey, Brazil, South Africa, China, and Bangladesh.<ref name="indiatimes"/><ref name="newtimes">{{cite news |last1=Byumvuhore |first1=Frederic |title=How Meril Life Science Products and services improve lives of people in Rwanda and across the globe… |url=https://www.newtimes.co.rw/article/161781/News/featured-how-meril-life-science-products-and-services-improve-lives-of-people-in-rwanda-and-across-the-globea |publisher=[[The New Times (Rwanda)|The New Times]] |date=December 10, 2018}}</ref>

It is also engaged in sale of specific medical devices like [[Surgical Robot]]s to hospitals. The company has established research and development (R&D) facilities focusing on [[orthopedics]], endosurgery, [[cardiovascular]] and [[In vitro diagnostics|in-vitro diagnostics]].<ref name="vccircle"/> As of February 2017, the company derived 50 percent of its revenue from international operations.<ref name="business-standard"/>

== Products ==
Meril Life Sciences is engaged in the development and manufacturing of medical devices used in various medical fields. In December 2018, Meril Life Sciences introduced the indigenously designed and manufactured Myval Transcatheter Aortic Heart Valve (TAVR),<ref>{{cite news |title=Indian device maker Meril Life Sciences joins big league with artificial heart valve technology |url=https://www.moneycontrol.com/news/business/companies/indian-device-maker-meril-life-sciences-joins-big-league-with-artificial-heart-valve-technology-3261871.html |publisher=[[Moneycontrol.com]] |date=December 7, 2018}}</ref><ref>{{cite news |title=India's First Artificial Heart Valve Technology Launched |url=https://www.ndtv.com/india-news/myval-indias-first-artificial-heart-valve-technology-launched-1959958 |publisher=[[NDTV]] |date=December 9, 2018}}</ref> making it the first Indian company to commercially launch Transcatheter Aortic Heart Valve replacement (TAVR) Therapy in the global market.<ref>{{cite news |title=Meril launches Myval TAVR |url=https://health.economictimes.indiatimes.com/news/medical-devices/meril-launches-myval-tavr/66997375 |publisher=[[The Economic Times]] |date=December 8, 2018}}</ref> The Myval TAVR technology received approval from the [[Central Drugs Standard Control Organisation|Central Drugs Standard Control Organization]] (CDSCO) in November 2018<ref>{{cite news |last1=Das |first1=Sanjiv |title=Meril Life Sciences bags CDSCO approval for Myval-TAVR technology |url=https://www.expresshealthcare.in/news/meril-life-sciences-bags-cdsco-approval-for-myval-tavr-technology/407221/ |publisher=Express Healthcare |date=November 16, 2018}}</ref> and obtained [[European Conformity]] in June 2019.<ref>{{cite news |title=Meril’s Myval Transcatheter Heart Valve receives CE approval |url=https://health.economictimes.indiatimes.com/news/medical-devices/merils-myval-transcatheter-heart-valve-receives-ce-approval/69690049 |publisher=[[The Economic Times]] |date=June 7, 2019}}</ref>

In March 2021 Meril Life Sciences launched the MeRes100 BRS, a 100-micron [[Bioresorbable scaffold]], which received approvals from the [[Drugs Controller General of India|Drug Controller General of India]] and [[European Conformity]].<ref>{{cite news |title=Meril Life Sciences launches indigenously developed bioresorbable scaffold |url=https://timesofindia.indiatimes.com/meril-life-sciences-launches-indigenously-developed-bioresorbable-scaffold/articleshow/81428009.cms |publisher=[[The Times of India]] |date=March 10, 2021}}</ref> In February 2022, the [[National Pharmaceutical Pricing Authority]], India's pharmaceutical regulator, granted a five-year rare exemption from price control for MeRes100 BRS under the provision of the [[Drug Price Control Orders|Drug Price Control Order]] 2013.<ref>{{cite news |title=Government exempts Meril's new coronary stent MeRes 100 from price control |url=https://www.cnbctv18.com/healthcare/government-exempts-merils-new-coronary-stent-meres-100-from-price-control-5398061.htm |publisher=[[CNBC TV18]] |date=February 29, 2020}}</ref><ref>{{cite news |last1=Rey |first1=Kalyan |title=Gujarat firm under scanner after stents kept out of price control |url=https://www.deccanherald.com/national/north-and-central/gujarat-firm-under-scanner-after-stents-kept-out-of-price-control-809569.html |publisher=[[Deccan Herald]] |date=March 1, 2020}}</ref> The development of MeRes100 took around two to three years to complete.<ref name="business-standard"/>

The company also has a range of [[surgical suture]]s, including absorbable and non-absorbable options like [[polydioxanone]] sutures, PGA & PGLA absorbable sutures, polyester sutures, and polypropylene sutures. It manufactures diagnostic equipment, reagents, and rapid tests for diseases such as [[Dengue fever|Dengue]], [[Subtypes of HIV|HIV 1 and 2]], [[Human chorionic gonadotropin|hCG]], Ag, [[Hepatitis C virus|HCV]], and [[Malaria]].<ref name="newtimes"/>

== COVID-19 ==
During the [[COVID-19 pandemic in India|COVID-19 pandemic]] in 2020, Meril manufactured its [[Rt pcr|RT-PCR]] [[COVID-19 test kit]].<ref>{{cite news |last1=Kaul |first1=Rhythma |title=Indian Covid-19 test kit production scaled up to lower imports |url=https://www.hindustantimes.com/india-news/indian-test-kit-production-scaled-up-to-lower-imports/story-W4EUSEvoQqCJnRHHGmC10K.html |publisher=[[Hindustan Times]] |date=May 10, 2020}}</ref> In June 2020, Meril Diagnostics was among the seven companies authorized by the [[Indian Council of Medical Research]] to manufacture the Covid Kavach [[ELISA]] [[IgG antibody]] test using Anti-body technology.<ref>{{cite news |last1=Kumar |first1=Mayank |title=Covid-19 testing: How India is testing to flatten the coronavirus curve; details |url=https://www.financialexpress.com/lifestyle/health/covid-19-testing-how-india-is-testing-to-flatten-the-coronavirus-curve-details/1992036/ |publisher=[[The Financial Express (India)|The Financial Express]] |date=June 15, 2020}}</ref>

The company developed CoviFind, a self-use [[Rapid antigen test]] for [[COVID-19]], which received approval from the Indian Council of Medical Research in June 2021, and is designed to provide results within approximately 15 minutes for individuals with a medium to high viral load of the virus.<ref>{{cite news |last1=Mishra |first1=Lalatendu |title=ICMR approves Meril’s self-use Rapid Antigen test kit for COVID-19 |url=http://www.thehindu.com/news/national/icmr-approves-merils-self-use-rapid-antigen-test-kit-for-covid-19/article34776422.ece |publisher=[[The Hindu]] |archive-url=http://web.archive.org/web/20210610065243/http://www.thehindu.com/news/national/icmr-approves-merils-self-use-rapid-antigen-test-kit-for-covid-19/article34776422.ece |archive-date=June 10, 2021}}</ref> In August 2021, cricketer [[MS Dhoni|Mahendra Singh Dhoni]] was appointed as the brand ambassador for CoviFind. He appeared in two digital films and TV commercials, promoting testing to consumers.<ref>{{cite news |title=Meril ropes in MS Dhoni as the face of its Covid-19 self-test kit |url=https://www.exchange4media.com/marketing-news/meril-ropes-in-ms-dhoni-as-the-face-of-its-covid-19-self-test-kit-115065.html |publisher=Exchange4Media |date=August 17, 2021}}</ref>

== Other activities ==
Meril runs the Meril Academy which provides education and training to healthcare personnel. It has organized numerous workshops and conferences in specialties including [[general surgery]], [[Diagnosis|diagnostics]], [[orthopedics]], [[interventional cardiology]], operation theater nursing, and [[hospital management]].<ref name="newtimes"/><ref>{{cite news |title=Vijayawada represents international meet on joint replacements |url=https://www.thehansindia.com/posts/index/Andhra-Pradesh/2018-10-15/Vijayawada-represents-international-meet-on-joint-replacements/425016 |publisher=[[The Hans India]] |date=October 15, 2018}}</ref>

== Awards and recognition ==
* It won the [[Frost & Sullivan]]'s Emerging Medical Technology Company of the Year at the India Healthcare Excellence Award in 2015.<ref>{{cite news |title=Frost & Sullivan hosts 7th Annual India Healthcare Excellence Awards 2015 in Mumbai |url=https://telradsol.com/wp-content/uploads/2018/08/Frost-Sullivan-hosts-7th-Annual-India-Healthcare-Excellence-Awards-2015-in-Mumbai.pdf |publisher=Pharmabiz |date=October 14, 2015}}</ref>
* In 2017, the [[Government of India]]'s [[Department of Pharmaceuticals]] awarded the company with the India Medical Devices Company of the Year Award and the India Medical Devices Export Company of the Year Award.<ref>{{cite web|title=List of 2nd India Pharma Awards|url=https://pharmaceuticals.gov.in/sites/default/files/List%20of%20%202nd%20India%20Pharma%20Award_0.pdf|website=Official website of the Department of Pharmaceuticals, Government of India}}</ref>
* In 2017, Meril Life Sciences was awarded the Innovative Model for CSR implementation award by the Gujarat CSR Authority, [[Government of Gujarat]], at the National CSR Conclave.<ref>{{cite book |title=GCSRA CSR Awards 2017 |publisher=Gujarat CSR Authority, Government of Gujarat |page=4 |url=http://gcsra.org/writereaddata/images/pdf/GCSRA-CSR-Awards-17.pdf}}</ref>
* In 2018, it received the Company of the Year Award in the Indian Cardiac Stents Provider category by [[Frost & Sullivan]].<ref>{{cite news |title=Frost & Sullivan gives 45 awards to Indian companies for their transformation journey |url=https://techobserver.in/2018/10/11/frost-sullivan-gives-45-awards-to-indian-companies-for-their-transformation-journey/ |publisher=Tech Observer |date=October 11, 2018}}</ref>
* In 2019, Meril Life Sciences was awarded the SME Business Excellence Award in the Mid-Corporate category by [[Dun & Bradstreet]] and [[RBL Bank]].<ref>{{cite book |title=Leading SMEs of India 2019 |date=2019 |publisher=[[Dun & Bradstreet]] |isbn=978-93-86214-36-2 |url=https://www.dnb.co.in/files/pdf/Leading%20SMEs%20of%20India%202019.pdf}}</ref>
* It received the Best Employer Award at the National Best Employer Brand Awards 2019 and 2022 by the Employer Branding Institute.<ref>{{cite web |title=National Employer Branding Winners 2022 |url=http://www.employerbrandingawards.com/winners/national-best-employer-brand/national-employer-branding-winners-2022.html |website=Employer Branding Awards |date=2023-06-26}}</ref><ref>{{cite web |title=Employer Branding Awards – National Best Employer Brand Winners 2019 |url=http://www.employerbrandingawards.com/winners/national-best-employer-brand/eb_win19.html |website=Employer Branding Awards |date=2023-06-26}}</ref>
* The company won the Indian Medical Device Innovation of the Year award at the 7th edition of India Pharma and Indian Medical Device 2022, by the [[Department of Pharmaceuticals]] and the [[Federation of Indian Chambers of Commerce & Industry|Federation of Indian Chambers of Commerce and Industry]] (FICCI).<ref>{{cite news |title=DoP announces Indian Pharma and Medical Devices Awards 2022 |url=http://pharmabiz.com/NewsDetails.aspx?aid=149345&sid=1 |work=Pharmabiz |date=April 28, 2022}}</ref> The award was given by [[Bhagwanth Khuba]], the Minister of State for the Ministry of Chemicals and Fertilisers, in April 2022.<ref>{{cite news|title=Shri Bhagwanth Khuba, Union Minister of State for Chemicals & Fertilizers presents India Pharma and India Medical Devices Awards 2022|url=https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1820554|publisher=[[Press Information Bureau]], [[Government of India]]|date=April 27, 2022}}</ref>

== References ==
{{reflist}}

{{DEFAULTSORT:Meril Life Sciences}}
[[Category:Medical device manufacturers]]
[[Category:Health care companies of India]]
[[Category:Medical equipment]]
[[Category:Companies based in Gujarat]]
[[Category:Medical and health organisations based in India]]
[[Category:Indian companies established in 2006]]

Meril Life Sciences - Revision history

Ajay Kumar: Creating a new article